Lumos Diagnostics Holdings Limited LDXHF
OTC PK
| 06/30/2026 | 03/31/2026 | ||||
|---|---|---|---|---|---|
| Revenue | 0.00% | 15.56% | |||
| Total Other Revenue | -- | -- | |||
| Total Revenue | 0.00% | 15.56% | |||
| Cost of Revenue | 0.00% | 70.26% | |||
| Gross Profit | 0.00% | -10.35% | |||
| SG&A Expenses | 0.00% | 7.94% | |||
| Depreciation & Amortization | 0.00% | 0.16% | |||
| Other Operating Expenses | -- | -- | |||
| Total Operating Expenses | 0.00% | 16.33% | |||
| Operating Income | 0.00% | -17.05% | |||
| Income Before Tax | 0.00% | 98.52% | |||
| Income Tax Expenses | -- | -- | |||
| Earnings from Continuing Operations | 0.00% | 98.52% | |||
| Earnings from Discontinued Operations | -- | -- | |||
| Extraordinary Item & Accounting Change | -- | -- | |||
| Minority Interest in Earnings | -- | -- | |||
| Net Income | 0.00% | 98.52% | |||
| EBIT | 0.00% | -17.05% | |||
| EBITDA | -4.70% | -33.76% | |||
| EPS Basic | -- | 100.00% | |||
| Normalized Basic EPS | 0.00% | -15.00% | |||
| EPS Diluted | 0.00% | 96.88% | |||
| Normalized Diluted EPS | 0.00% | -15.00% | |||
| Average Basic Shares Outstanding | 0.00% | 10.61% | |||
| Average Diluted Shares Outstanding | 0.00% | 10.61% | |||
| Dividend Per Share | -- | -- | |||
| Payout Ratio | -- | -- | |||